1263 related articles for article (PubMed ID: 24161427)
21. Delineation of target volume for radiotherapy of high-grade gliomas by 99m Tc-MIBI SPECT and MRI fusion.
Krengli M; Loi G; Sacchetti G; Manfredda I; Gambaro G; Brambilla M; Carriero A; Inglese E
Strahlenther Onkol; 2007 Dec; 183(12):689-94. PubMed ID: 18040614
[TBL] [Abstract][Full Text] [Related]
22. Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients.
Vees H; Senthamizhchelvan S; Miralbell R; Weber DC; Ratib O; Zaidi H
Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):182-93. PubMed ID: 18818918
[TBL] [Abstract][Full Text] [Related]
23. Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.
Youland RS; Pafundi DH; Brinkmann DH; Lowe VJ; Morris JM; Kemp BJ; Hunt CH; Giannini C; Parney IF; Laack NN
J Neurooncol; 2018 May; 137(3):583-591. PubMed ID: 29330751
[TBL] [Abstract][Full Text] [Related]
24. Target volume delineation in oropharyngeal cancer: impact of PET, MRI, and physical examination.
Thiagarajan A; Caria N; Schöder H; Iyer NG; Wolden S; Wong RJ; Sherman E; Fury MG; Lee N
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):220-7. PubMed ID: 22035663
[TBL] [Abstract][Full Text] [Related]
25. FET-PET for malignant glioma treatment planning.
Niyazi M; Geisler J; Siefert A; Schwarz SB; Ganswindt U; Garny S; Schnell O; Suchorska B; Kreth FW; Tonn JC; Bartenstein P; la Fougère C; Belka C
Radiother Oncol; 2011 Apr; 99(1):44-8. PubMed ID: 21458093
[TBL] [Abstract][Full Text] [Related]
26. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer.
Dalah E; Moraru I; Paulson E; Erickson B; Li XA
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):633-40. PubMed ID: 24755533
[TBL] [Abstract][Full Text] [Related]
27. Impact of
Debus C; Waltenberger M; Floca R; Afshar-Oromieh A; Bougatf N; Adeberg S; Heiland S; Bendszus M; Wick W; Rieken S; Haberkorn U; Debus J; Knoll M; Abdollahi A
Sci Rep; 2018 May; 8(1):7201. PubMed ID: 29740097
[TBL] [Abstract][Full Text] [Related]
28. Impact of 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: the referring physician's perspective.
Walter F; Cloughesy T; Walter MA; Lai A; Nghiemphu P; Wagle N; Fueger B; Satyamurthy N; Phelps ME; Czernin J
J Nucl Med; 2012 Mar; 53(3):393-8. PubMed ID: 22323780
[TBL] [Abstract][Full Text] [Related]
29. Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.
Karki K; Saraiya S; Hugo GD; Mukhopadhyay N; Jan N; Schuster J; Schutzer M; Fahrner L; Groves R; Olsen KM; Ford JC; Weiss E
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):80-89. PubMed ID: 28816167
[TBL] [Abstract][Full Text] [Related]
30. Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.
Pafundi DH; Laack NN; Youland RS; Parney IF; Lowe VJ; Giannini C; Kemp BJ; Grams MP; Morris JM; Hoover JM; Hu LS; Sarkaria JN; Brinkmann DH
Neuro Oncol; 2013 Aug; 15(8):1058-67. PubMed ID: 23460322
[TBL] [Abstract][Full Text] [Related]
31. Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastoma.
Popp I; Bott S; Mix M; Oehlke O; Schimek-Jasch T; Nieder C; Nestle U; Bock M; Yuh WTC; Meyer PT; Weber WA; Urbach H; Mader I; Grosu AL
Radiother Oncol; 2019 Jan; 130():121-131. PubMed ID: 30219612
[TBL] [Abstract][Full Text] [Related]
32. Target definition by C11-methionine-PET for the radiotherapy of brain metastases.
Matsuo M; Miwa K; Shinoda J; Kako N; Nishibori H; Sakurai K; Yano H; Iwama T; Kanematsu M
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):714-22. PubMed ID: 19095373
[TBL] [Abstract][Full Text] [Related]
33. Utilizing 18F-fluoroethyl-l-tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRI.
Jaymanne DT; Kaushal S; Chan D; Schembri G; Brazier D; Bailey D; Wheeler H; Back M
J Med Imaging Radiat Oncol; 2018 Feb; 62(1):122-127. PubMed ID: 28980392
[TBL] [Abstract][Full Text] [Related]
34. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
[TBL] [Abstract][Full Text] [Related]
35. 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
Ledezma CJ; Chen W; Sai V; Freitas B; Cloughesy T; Czernin J; Pope W
Eur J Radiol; 2009 Aug; 71(2):242-8. PubMed ID: 18511228
[TBL] [Abstract][Full Text] [Related]
36. 18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.
Karunanithi S; Sharma P; Kumar A; Khangembam BC; Bandopadhyaya GP; Kumar R; Gupta DK; Malhotra A; Bal C
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1025-35. PubMed ID: 23525498
[TBL] [Abstract][Full Text] [Related]
37. Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.
Cardoso M; Min M; Jameson M; Tang S; Rumley C; Fowler A; Estall V; Pogson E; Holloway L; Forstner D
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):399-407. PubMed ID: 30816646
[TBL] [Abstract][Full Text] [Related]
38. Variability of gross tumour volume delineation: MRI and CT based tumour and lymph node delineation for lung radiotherapy.
Kumar S; Holloway L; Boxer M; Yap ML; Chlap P; Moses D; Vinod S
Radiother Oncol; 2022 Feb; 167():292-299. PubMed ID: 34896156
[TBL] [Abstract][Full Text] [Related]
39. Identify glioma recurrence and treatment effects with triple-tracer PET/CT.
Li C; Yi C; Chen Y; Xi S; Guo C; Yang Q; Wang J; Sai K; Zhang J; Ke C; Chen F; Lv Y; Zhang X; Chen Z
BMC Med Imaging; 2021 May; 21(1):92. PubMed ID: 34059015
[TBL] [Abstract][Full Text] [Related]
40. Can (18)F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study.
Karunanithi S; Sharma P; Kumar A; Gupta DK; Khangembam BC; Ballal S; Kumar R; Kumar R; Bal C
Eur J Radiol; 2014 Jan; 83(1):219-25. PubMed ID: 24191944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]